Investment advice you can actually understand
Results 11 - 20 of 601 : Previous 1 2 3 4 5 6 7 8 9 Next
Hepatitis C Drugmakers Hook Up to Develop Cocktail
Merck and Bristol-Myers Squibb are the latest to join forces.
Bristol-Myers Expanding Biologics Facility
Massachusetts project will support growing pipeline of investigational medicines and potential new products.
Is Bristol-Myers Squibb Destined for Greatness?
Let's see what the numbers say about Bristol-Myers (BMY).
Tackling Cancer: Melanoma's Biggest Current & Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.
Understanding Why Cancer Vaccines Fail
The immune system attacks the injection site.
Should AstraZeneca and Bristol-Myers Squibb Get Married?
A merger between these two companies could be a match made in heaven.
Johnson & Johnson Invokana PDUFA Preview
This type-2 diabetes drug should face no problem gaining approval, but that's not the end of the story.
Pharmaceuticals: Just What the Dow Ordered
Though it's had a few down days, the Dow is on a big upswing and big pharma is right alongside it.
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.
3 Big Concerns for the Pharmaceutical Industry
An aging population represents opportunity galore for the pharmaceutical industry -- but only if you understand these three risks.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK